Estimating glomerular filtration rate in acute coronary syndromes: Different equations,different mortality risk prediction

Abstract

Aims:

Renal dysfunction is a powerful predictor of adverse outcomes in patients hospitalized for acute coronary syndrome. Three new glomerular filtration rate (GFR) estimating equations recently emerged, based on serum creatinine (CKD-EPI_creat), serum cystatin C (CKD-EPI_cyst) or a combination of both (CKD-EPI_creat/cyst), and they are currently recommended to confirm the presence of renal dysfunction. Our aim was to analyse the predictive value of these new estimated GFR (eGFR) equations regarding mid-term mortality in patients with acute coronary syndrome, and compare them with the traditional Modification of Diet in Renal Disease (MDRD-4) formula.

Methods and results:

801 patients admitted for acute coronary syndrome (age 67.3±13.3 years, 68.5% male) and followed for 23.6±9.8 months were included. For each equation, patient risk stratification was performed based on eGFR values: high-risk group (eGFR<60ml/min per 1.73m²) and low-risk group (eGFR⩾60ml/min per 1.73m²). The predictive performances of these equations were compared using area under each receiver operating characteristic curves (AUCs). Overall risk stratification improvement was assessed by the net reclassification improvement index. The incidence of the primary endpoint was 18.1%. The CKD-EPI_cyst equation had the highest overall discriminate performance regarding mid-term mortality (AUC 0.782±0.20) and outperformed all other equations (ρ<0.001 in all comparisons). When compared with the MDRD-4 formula, the CKD-EPI_cyst equation accurately reclassified a significant percentage of patients into more appropriate risk categories (net reclassification improvement index of 11.9% (p=0.003)). The CKD-EPI_cyst equation added prognostic power to the Global Registry of Acute Coronary Events (GRACE) score in the prediction of mid-term mortality.

Conclusion:

The CKD-EPI_cyst equation provides a novel and improved method for assessing the mid-term mortality risk in patients admitted for acute coronary syndrome, outperforming the most widely used formula (MDRD-4), and improving the predictive value of the GRACE score. These results reinforce the added value of cystatin C as a risk marker in these patients.

Keywords

Acute coronary syndrome glomerular filtration rate kidney function cystatin C risk stratification prognosis

Get full access to this article

View all access options for this article.

References

Al Suwaidi

Reddan

Williams

., for the GUSTO-IIb, GUSTO-III, PURSUIT, and PARAGON-A Investigators. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974–980.

Hamm

Bassand

Agewall

. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32: 2999-3054.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1–150.

Cockcroft

Gault

. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31–41.

Levey

Coresh

Greene

. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247–254.

Barra

Providência

Silva

. Glomerular filtration rate: Which formula should be used in patients with myocardial infarction? Rev Port Card 2012; 31: 493–502.

Laterza

Price

Scott

. Cystatin C: An improved estimator of glomerular filtration rate. Clin Chem 2002; 48: 699–707.

Taglieri

Koenig

Kaski

. Cystatin C and cardiovascular risk. Clin Chem 2009; 55: 1932–1943.

Shilpak

Sarnak

Katz

. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049–2060.

10.

Levey

Stevens

Schmid

. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.

11.

Matsushita

Mahmoodi

Woodward

. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941–1950.

12.

Inker

Schmid

Tighiouart

. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20–29.

13.

Pencina

Steyerberg

D’Agostino

. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30: 11–21.

14.

Newman

. Cystatin C. Ann Clin Biochem 2002; 39: 89–104.

15.

Chu

Wang

Chang

. Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clin Chim Acta 2004; 341: 133–138.

16.

Fricker

Wiesli

Brändle

. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003; 63: 1944–1947.

17.

Filler

Bökenkamp

Hofmann

. Cystatin C as a marker of GFR – history, indications, and future research. Clin Biochem 2005; 38: 1–8.

18.

Bökenkamp

Laarman

CARC

Braam

. Effect of corticosteroid therapy on low-molecular-weight protein markers of kidney function. Clin Chem 2007; 53; 2219–2221.

19.

Inker

Schmid

Tighiouart

. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367; 20–29.

20.

Grubb

Nyman

Björk

. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan–Barratt prediction equations for children. Clin Chem 2005; 51: 1420–1431.

21.

Ferraro

Marano

Biganzoli

. Prognostic value of cystatin C in acute coronary syndromes: Enhancer of atherosclerosis and promising therapeutic target. Clin Chem Lab Med 2011; 49: 1937–1404.

22.

Acuña

JMG

González-Babarro

Shamagian

. Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome. Rev Esp Cardiol 2009; 62: 510–519.

23.

Parikh

Hwang

Yang

. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 2008; 102: 1194–1198.

24.

Svensson-Färbom

Andersson

Almgren

. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease. J Intern Med 2014; 275: 506–521.

25.

Shlipak

Sarnak

Katz

. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049–2060.

26.

Jernberg

Lindahl

James

. Cystatin C: A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004; 110: 2342–2348.

27.

Ristiniemi

Lund

Tertti

. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome. Clin Biochem 2012; 45: 535–540.

28.

Ichimoto

Kobayashi

. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction. Circ J 2009; 73: 1669–1673.

29.

Åkerblom

Wallentin

Siegbahn

. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST elevation acute coronary syndromes: Results from the PLATelet Inhibition and Patient Outcomes Study. Clin Chem 2012; 58: 190–199.

30.

Zamora

Lúpon

Antonio

. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C. Clin Chem 2014; 60: 481–489.

31.

Lassus

Harjola

Sund

. Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 2007; 28: 1841–1847.

32.

Shlipak

Matsushita

Ärnlöv

. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; 369: 932–943.

33.

Abu-Assi

Raposeiras-Roubin

Riveiro-Cruz

. Creatinine-or cystatin C-based equations to estimate glomerular filtration rate in acute myocardial infarction: A disparity in estimating renal function and in mortality risk prediction. Int J Cardiol 2013; 168: 4300–4301.

34.

Earley

Miskulin

Lamb

. Estimating equations for glomerular filtration rate in the era of creatinine standardization. Ann Intern Med 2012; 156: 785–795.

35.

Morici

Servi

Toso

. Renal function estimation and one-year mortality in elderly patients with non-ST-segment elevation acute coronary syndromes. Int J Cardiol 2014; 174: 127–128.